Menopause Affects Women Differently

Menopause Affects Women Differently.
Women bothered by steaming flashes or other clobber of menopause have a number of treatment options - hormonal or not, according to updated guidelines from the American College of Obstetricians and Gynecologists. It's estimated that anywhere from 50 percent to 82 percent of women succeeding through menopause have fierce flashes - sudden feelings of extreme warmness in the upper body - and night sweats vigrx top. For many, the symptoms are frequent and severe enough to cause catch problems and disrupt their daily lives.

And the duration of the misery can last from a couple years to more than a decade, says the college, the nation's unsurpassed group of ob/gyns. "Menopausal symptoms are common, and can be very bothersome to women," said Dr Clarisa Gracia, who helped make out the new guidelines. "Women should differentiate that effective treatments are available to address these symptoms" can water kefir cause pain in the joints?. The guidelines, published in the January proclamation of Obstetrics andamp; Gynecology, reinforce some longstanding advice: Hormone therapy, with estrogen desolate or estrogen plus progestin, is the most effective way to cool hot flashes.

But they also have sex out the growing evidence that some antidepressants can help an associate professor of obstetrics and gynecology at the University of Pennsylvania in Philadelphia. In studies, scurrilous doses of antidepressants such as venlafaxine (Effexor) and fluoxetine (Prozac) have helped soften hot flashes in some women. And two other drugs - the anti-seizure sedative gabapentin and the blood pressure medication clonidine - can be effective, according to the guidelines.

So far, though, only one non-hormonal painkiller is actually approved by the US Food and Drug Administration for treating touchy flashes: a low-dose version of the antidepressant paroxetine (Paxil). And experts said that while there is basis some hormone alternatives ease hot flashes, none works as well as estrogen and estrogen-progestin. "Unfortunately, many providers are edgy to prescribe hormones.

And a lot of the time, women are fearful," said Dr Patricia Sulak, an ob/gyn at Scott andamp; White Hospital in Temple, Texas, who was not intricate in belles-lettres the new guidelines. Years ago, doctors routinely prescribed hormone replacement cure after menopause to lower women's risk of heart disease, among other things. But in 2002, a portly US trial called the Women's Health Initiative found that women given estrogen-progestin pills absolutely had slightly increased risks of blood clots, heart attack and breast cancer. "Use of hormones plummeted" after that.

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy.
In a pronouncement that seems to table the prevailing wisdom that any form of hormone replacement remedial programme raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone psychoanalysis might protect a small subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone psychotherapy is actually protective" in women who have a low risk for developing chest tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver vigrx scriptovore.com. With his colleagues, Ragaz took another aspect at text from the Women's Health Initiative (WHI) study, a native trial that has focused on ways to prevent breast and colorectal cancer, as well as focus disease and fracture risk, in postmenopausal women.

The team planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by out of doors experts, uncharacteristic studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary fav-store.net. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.

Two groups were limited of the try - women who had had hysterectomies and took estrogen unexcelled as hormone replacement therapy and a group that took estrogen plus progestin hormone replacement therapy. The mix therapy trial was halted in 2002 after it became clear those women were at increased danger for heart disease and breast cancer.

In the new look at the estrogen-only group "we looked at women who did not have high-risk features". They found that women with no ex history of benign teat disease had a 43 percent reduction breast cancer risk on estrogen; women with no subdivision history with a first-degree relative with breast cancer had a 32 percent risk reduction and women without above hormone use had a 32 percent reduced risk.

Reduction The Hormone Estrogen Leads To Mental Decline

Reduction The Hormone Estrogen Leads To Mental Decline.
The younger a cleaning woman is when she undergoes surgical menopause, the greater her chances of developing recollection problems at an earlier age, supplementary research suggests. Surgical menopause describes the end of ovarian rite due to gynecological surgery before the age of natural menopause. It involves the removal of one or both ovaries (an oophorectomy), often in union with a hysterectomy, the removal of a woman's uterus howporstarsgrowit com. "For women with surgically induced menopause, primordial age at menopause was associated with a faster decline in memory," said swotting author Dr Riley Bove, an instructor in neurology at Harvard Medical School and an confidant neurologist at Brigham and Women's Hospital in Boston.

However "These are very preliminary data". Bove said other inspection suggests a link between a decrease in the hormone estrogen during menopause and mental decline, and the ambition of this study was to better understand the relationship between reproductive-health factors and memory changes zydip-c lotion hinde. The study results will be presented in March at the American Academy of Neurology' annual meeting, in San Diego.

For the study, the researchers analyzed medical records of more than 1800 women ancient 53 to 100 who were taking fragment in one of two studies conducted by Rush University Medical Center in Chicago: the Religious Orders Study and the Memory and Aging Project. The researchers assessed reproductive variables, such as when women had their outset period, the reckon of years menstrual cycles lasted, and use of hormone replacement therapies. Measurements from several types of point of view and retention tests were analyzed, too.

The scientists also assessed the results of percipience biopsies after death, some of which showed the presence of Alzheimer's plaques. "We had approximately 580 brains within reach for analysis - this speaks to the very unique and rich nature of the data". Thirty-three percent of the read participants had undergone surgical menopause.

Reasons for these surgeries may include fibroids (noncancerous uterine tumors), endometriosis (growth of uterine chain outside the womb), cancer of the uterus and ovaries, and irregular vaginal bleeding. When the ovaries are gone, ovarian production of estrogen stops, said Bove. However, this inspect did not include reasons why the women underwent surgical menopause.